West Pharmaceutical Servi... (WST)
212.00
1.30 (0.62%)
At close: Apr 14, 2025, 3:14 PM
0.62% (1D)
| Bid | 211.76 |
| Market Cap | 15.33B |
| Revenue (ttm) | 2.89B |
| Net Income (ttm) | 492.7M |
| EPS (ttm) | 6.7 |
| PE Ratio (ttm) | 31.64 |
| Forward PE | 45.66 |
| Analyst | Buy |
| Ask | 212.24 |
| Volume | 323,626 |
| Avg. Volume (20D) | 1,041,163 |
| Open | 213.58 |
| Previous Close | 210.70 |
| Day's Range | 208.93 - 213.58 |
| 52-Week Range | 187.43 - 394.42 |
| Beta | 1.22 |
About WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom so...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Mar 17, 1980
Employees 10,600
Stock Exchange NYSE
Ticker Symbol WST
Website https://www.westpharma.com
Analyst Forecast
According to 6 analyst ratings, the average rating for WST stock is "Buy." The 12-month stock price forecast is $355, which is an increase of 67.45% from the latest price.
Stock ForecastsNext Earnings Release
West Pharmaceutical Services Inc. is scheduled to release its earnings on Apr 24, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-38.22%
West Pharmaceutical Services shares are trading lo...
Unlock content with
Pro Subscription
4 months ago
+4.21%
West Pharmaceutical Services shares are trading higher after UBS upgraded the stock from Neutral to Buy and raised its price target from $350 to $390.
